Literature DB >> 26965015

Comments on 'Long-term outcomes of phakic patients with diabetic macular oedema treated with intravitreal fluocinolone acetonide (FAc) implants'.

B Takkar1, S Azad1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26965015      PMCID： PMC4941056          DOI： 10.1038/eye.2016.27

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  5 in total

1.  Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema.

Authors:  Peter A Campochiaro; David M Brown; Andrew Pearson; Thomas Ciulla; David Boyer; Frank G Holz; Michael Tolentino; Amod Gupta; Lilianne Duarte; Steven Madreperla; John Gonder; Barry Kapik; Kathleen Billman; Frances E Kane
Journal:  Ophthalmology       Date:  2011-04       Impact factor: 12.079

2.  Clinical outcomes of clear lens extraction in eyes with primary angle closure.

Authors:  Tanuj Dada; Anubha Rathi; Dewang Angmo; Tushar Agarwal; Murugesan Vanathi; Sudarshan K Khokhar; Rasik B Vajpayee
Journal:  J Cataract Refract Surg       Date:  2015-07       Impact factor: 3.351

3.  Higher-order aberrations of lenticular opacities.

Authors:  Nisha Sachdev; Susan E Ormonde; Trevor Sherwin; Charles N J McGhee
Journal:  J Cataract Refract Surg       Date:  2004-08       Impact factor: 3.351

4.  Long-term outcomes of phakic patients with diabetic macular oedema treated with intravitreal fluocinolone acetonide (FAc) implants.

Authors:  Y Yang; C Bailey; F G Holz; N Eter; M Weber; C Baker; S Kiss; U Menchini; J M Ruiz Moreno; P Dugel; A Lotery
Journal:  Eye (Lond)       Date:  2015-06-26       Impact factor: 3.775

Review 5.  Intravitreal steroids for the treatment of retinal diseases.

Authors:  Valentina Sarao; Daniele Veritti; Francesco Boscia; Paolo Lanzetta
Journal:  ScientificWorldJournal       Date:  2014-01-08
  5 in total
  1 in total

1.  Reply to 'Comments on Long-term outcomes of phakic patients with diabetic macular oedema treated with intravitreal fluocinolone acetonide (FAc) implants'.

Authors:  Y Yang; C Bailey; F G Holz; N Eter; M Weber; C Baker; S Kiss; U Menchini; J M Ruiz Moreno; P Dugel; A Lotery
Journal:  Eye (Lond)       Date:  2016-03-11       Impact factor: 3.775
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.